AWAriane Willems

Ariane Willems

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ariane Willems has a total of 84 co-authors. Here are the top co-authors by number of shared publications:

  • Denis Schmartz

    Queen Fabiola Univ, Univ Hosp Brugmann, Childrens Hosp, Dept Anesthesiol, Brussels, Belgium

    3 shared publications
  • Oliver Karam

    Yale School of Medicine

    3 shared publications
  • Philippe Van der Linden

    From the Paediatric Intensive Care Unit, Department of Intensive Care, Leiden University Medical Centre, Leiden, The Netherlands (AW), Department of Anaesthesiology, University Hospital Brugmann and Queen Fabiola University Children's Hospital, Brussels, Belgium (SA, DS, PVL)

    3 shared publications
  • Françoise De Groote

    From the Paediatric Intensive Care Unit, Department of Intensive Care, Leiden University Medical Centre, Leiden, The Netherlands (AW), Department of Anaesthesiology, University Hospital Brugmann and Queen Fabiola University Children's Hospital, Brussels, Belgium (F-DG, DS, P-VdL) and Ars Statistica, Nivelles, Belgium (JF-F)

    2 shared publications
  • Jean-François Fils

    Ars Stat, Nivelles, Belgium

    2 shared publications
  • Adam M. Vogel

    Departments of Surgery and Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX

    1 shared publication

Latest Publications

  • Open Access

    Automatic Lung Aeration Assessment for Lung Ultrasound Imaging in the Pediatric Intensive Care Unit

    by Sabien G. J. Heisterkamp, Tharanghi Logendran, Ariane Willems, Can Ozan Tan

    Imaging of the lungs is traditionally based on chest X-ray as a first-line imaging method for lung aeration assessment. However, radiation exposure limits its use for patients in the pediatric intensive care unit. Lung ultrasonography (LUS) is a suitable alternative, but its interpretation is highly observer-dependent and requires sufficient experience and skill. We sought to develop a model based on deep learning to assist the clinician in the interpretation of LUS observations. In this retrospective, single-center, proof-of-concept study, all patients, age 0–18 years old admitted at the PICU of the Leiden University Medical Center (LUMC) between January and May 2022 who underwent an LUS were included. LUS video frames were analyzed using a deep learning tool; a conditional generative adversarial network (cGAN) was developed to generate segmentation masks containing clinical features from individual LUS frames. A total of 31 patients, with a median age of 2.5 months (IQR 0–11 months), were analyzed. A total of 98 LUS assessments and 506 4-s videos were collected. The median LUS score was 12 (IQR 8–17). The two best-performing frame-based segmentation models achieved mean Dice similarity coefficients of 0.97 ± 0.03 and 0.96 ± 0.03, with mean squared errors of 0.025 ± 0.025 and 0.030 ± 0.026, respectively. These findings demonstrate that a pediatric-specific cGAN can segment key LUS features from individual frames. However, the results derive from a small, single-center cohort with a frame-level rather than patient-level data split, and no formal clinical validation; independent, prospectively collected validation cohorts are required before any clinical implementation.

  • Use of delirium screening tools in the pediatric ICU: unnecessarily burdensome

    by Ariane Willems, Oliver Karam

    Purpose of review: Delirium screening is widely recommended in pediatric ICUs, despite persistent uncertainty about what delirium represents biologically, how accurately it can be measured, and whether its detection improves outcomes. Screening tools are increasingly embedded into routine care, even as concerns grow about overdiagnosis, workflow burden, and the absence of effective, evidence-based treatments. Recent findings: Delirium in critically ill children reflects heterogeneous acute brain dysfunction rather than a single disease entity. Validated screening tools show variable reliability and specificity, particularly in infants, children with neurodevelopmental delay, and those speaking a different language than the evaluator. Real-world implementation is limited by subjectivity and substantial nursing cognitive burden. Although delirium is associated with worse outcomes, evidence that screening or pharmacologic treatment alters these outcomes is weak. Pediatric drug trials are scarce, largely retrospective, and show inconsistent benefits with measurable risks. Summary: Current evidence does not support routine delirium screening as a strategy that improves outcomes in critically ill children. Given limited diagnostic precision and lack of effective therapies, clinical and research efforts should prioritize universal prevention strategies that target modifiable drivers of acute brain dysfunction, rather than widespread screening for a poorly defined and variably measured syndrome.

  • Open Access

    Protocols for anticoagulation management in pediatric extracorporeal membrane oxygenation: A comparative retrospective study

    by Mirte L. Jansen, Nina C. Boom, Nienke Schalij, Peter Paul Roeleveld, Eelco Van Es, Oliver Karam, Ariane Willems

    Introduction: In children undergoing Extracorporeal Membrane Oxygenation (ECMO), anticoagulation is given to counterbalance the risk of thrombosis. Several laboratory tests are available to monitor heparin, but the ideal method still needs to be determined. Methods: This retrospective cohort study included all patients under 18 years on ECMO support between 2010 and 2021. At our institution, the test used to monitor unfractionated heparin changed over time, dividing patients into three periods, using either activated clotting time (ACT) (2010-2014), activated partial thromboplastin time (aPTT) (2014-2018) or anti-Xa (2018-2021). The primary objective was to compare the occurrence of hemorrhagic complications. Secondary objectives included thrombotic complications, neurological complications, and survival. Results: We included 118 ECMO runs of which 30 ACT-guided, 40 aPTT-guided, and 48 anti-Xa-guided. No statistically significant differences were found in hemorrhagic complications [respectively 46.7% vs. 52.5% vs. 60.4%; p = 0.48], thrombotic complications ( p = 0.15), neurological complications ( p = 0.13), or 30-days survival ( p = 0.84). Duration of ECMO and length of hospital stay were both the shortest in the anti-Xa-guided group (respectively p = 0.02; p = 0.02). During ECMO, the anti-Xa-guided group received a higher unfractionated heparin dose compared to the aPTT- and ACT-guided group [respectively 839 [651–981] vs. 543 [407–692] vs. 330 [223–489] IU/kg d -1 , p < 0.001]. Conclusion: In our study, the test or titration method used to guide heparin-dosing in children on ECMO, was not associated with hemorrhagic complications and death. Of note, the dose of unfractionated heparin was significantly higher in the anti-Xa-guided group. Combined testing may be more effective than a single method, more studies are needed to establish the optimal strategy.

  • Lactate and gastrointestinal complications during enteral nutrition in pediatric ECMO patients: a retrospective cohort study

    by Bruna Pinheiro Machado, Yadigar Ziylan, Alexia Detheux, Ariane Willems, Viviane De Maertelaer, Corinne De Laet, Shancy Rooze

    Early enteral nutrition in patients undergoing extracorporeal membrane oxygenation (ECMO) is particularly challenging due to metabolic instability, feeding intolerance, and the risk of intestinal ischemia. This study aimed to identify risk factors for gastrointestinal intolerance (GI) and necrotizing enterocolitis (NEC) in pediatric patients supported with veno-arterial (VA) or veno-venous (VV) ECMO. This monocentric and retrospective cohort study involved 127 pediatric patients who underwent ECMO in the pediatric intensive care unit of the Queen Fabiola Children’s University Hospital, Belgium, between January 2011 and December 2023. Diarrhea on Day 2 (D2) occurred in 13.7% of the VV-ECMO patients (10/73) but not in any of the VA-ECMO patients (p = 0.013). The frequencies of other gastrointestinal symptoms, such as vomiting, abdominal distension, and gastrointestinal hemorrhage, did not significantly differ between the groups during the study period. NEC occurred in 5.1% of VV-ECMO patients (4/78) and 10.2% of VA-ECMO patients (5/49) (p = 0.230). Enteral nutrition was initiated within 48 h of ECMO cannulation in 110/127 patients (86.6%). Patients who presented with gastrointestinal complications on D2 had a low lactate value at ECMO initiation (3.61 ± 0.56 mmol/l versus 5.42 ± 0.44 mmol/l (p = 0.013)) and a low PRISM (19 ± 3 versus 25 ± 1 (p = 0.033)) and PIM (12 ± 5 versus 18 ± 2 (p = 0.288)). Patients with NEC presented non significantly higher lactate levels on D0 and D2. Lactatemia was significantly lower for living patients on D0 and D2. Conclusion: This study suggests that early EN in pediatric ECMO patients should be approached with caution. Mild digestive complications can occur, and the incidence of NEC can be high. High lactate levels at ECMO cannulation appear to be associated with severe complications such as death and NEC. What is Known: • Hyperlactatemia is a valuable indicator of low tissue perfusion. What is New: • The findings of this study suggest that patients who developed NEC had higher lactate levels at the time of cannulation than at the time of NEC diagnosis. • Lactatemia seems to be a risk factor for severe complications such as NEC and death rather than a risk factor for mild GI complications.


  • Open Access

    Priorities for Clinical Research in Pediatric Extracorporeal Membrane Oxygenation Anticoagulation From the Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference

    by Jennifer A. Md Muszynski, Melania M. Bembea, Alison Mlis Gehred, Elizabeth Mlis Lyman, Katherine Do Cashen, Ira M. Cheifetz, Heidi J. Dalton, Adam S. Himebauch, Oliver Karam, Katie M. Mbbs Moynihan, et al.

    OBJECTIVES: To identify and prioritize research questions for anticoagulation and hemostasis management of neonates and children supported with extracorporeal membrane oxygenation (ECMO) from the Pediatric ECMO Anticoagulation CollaborativE (PEACE) consensus. DATA SOURCES: Systematic review was performed using PubMed, EMBASE, and Cochrane Library (CENTRAL) databases from January 1988 to May 2021, followed by serial consensus conferences of international, interprofessional experts in the management of ECMO for critically ill neonates and children. STUDY SELECTION: The management of ECMO anticoagulation for critically ill neonates and children. DATA EXTRACTION: Within each of the eight subgroups, two authors reviewed all citations independently, with a third independent reviewer resolving any conflicts. DATA SYNTHESIS: Following the systematic review of MEDLINE, EMBASE, and Cochrane Library databases from January 1988 to May 2021, and the consensus process for clinical recommendations and consensus statements, PEACE panel experts constructed research priorities using the Child Health and Nutrition Research Initiative methodology. Twenty research topics were prioritized, falling within five domains (definitions and outcomes, therapeutics, anticoagulant monitoring, protocolized management, and impact of the ECMO circuit and its components on hemostasis). CONCLUSIONS: We present the research priorities identified by the PEACE expert panel after a systematic review of existing evidence informing clinical care of neonates and children managed with ECMO. More research is required within the five identified domains to ultimately inform and improve the care of this vulnerable population.


  • The choice of perioperative inotropic support impacts the outcome of small infants undergoing complex cardiac surgery: an observational study

    by Ariane Willems, Renaud Havaux, Denis Schmartz, Jean-François Fils, Françoise DE Pooter, Philippe VAN DER Linden

    Article: The choice of perioperative inotropic support impacts the outcome of small infants undergoing complex cardiac surgery: an observational study - Minerva Anestesiologica 2023 September;89(9):753-61 - Minerva Medica - Journals


  • Open Access

    Fluid Overload in Pediatric Univentricular Patients Undergoing Fontan Completion

    by Victorien A. C. Luppes, Ariane Willems, Mark G. Hazekamp, Nico A. Blom, Arend D. J. Ten Harkel

    Background: Fluid overload (FO) is known to occur frequently after pediatric cardiac surgery and is associated with morbidity and mortality. Fontan patients are at risk to develop FO due to their critical fluid balance. Furthermore, they need an adequate preload in order to maintain adequate cardiac output. This study aimed to identify FO in patients undergoing Fontan completion and the impact of FO on pediatric intensive care unit (PICU) length of stay (LOS) and cardiac events, defined as death, cardiac re-surgery or PICU re-hospitalization during follow-up. Methods: In this retrospective single center study, the presence of FO was assessed in 43 consecutive children undergoing Fontan completion. Results: Patients with more than 5% maximum FO had an extended PICU LOS (3.9 [2.9–6.9] vs. 1.9 [1.0–2.6] days; p < 0.001) and an increased length of mechanical ventilation (21 [9–121] vs. 6 [5–10] h; p = 0.001). Regression analysis demonstrated that an increase of 1% maximum FO was associated with a prolonged PICU LOS of 13% (95% CI 1.042–1.227; p = 0.004). Furthermore, patients with FO were at higher risk to develop cardiac events. Conclusions: FO is associated with short-term and long-term complications. Further studies are needed to determine the impact of FO on the outcome in this specific population.


  • Effect of a balanced colloid on acute kidney injury in paediatric cardiac surgery

    by Ariane Willems, Simon Arend, Denis Schmartz, Philippe Van der Linden


  • Does a balanced colloid decrease perioperative blood loss in paediatric cardiac surgery

    by Ariane Willems, Françoise De Groote, Denis Schmartz, Jean-François Fils, Philippe Van der Linden

    BACKGROUND Unbalanced fluid solutions cause metabolic acidosis and could be associated with impaired coagulation and increased blood loss. OBJECTIVE To investigate whether the use of a balanced colloid compared with a saline colloid for peri-operative fluid therapy in children undergoing cardiac surgery is associated with decreased blood loss and exposure to blood products. DESIGN Double-blinded randomised controlled trial. SETTING Tertiary children's hospital from 2013 to 2016. PATIENTS Children older than 29 days and younger than 3 years admitted for cardiac surgery with cardiopulmonary bypass (CPB). Exclusion criteria were emergency cardiac surgery, moribund (American Society of Anesthesiologists 5), Jehovah's witnesses, coagulopathy, renal failure, liver injury, intracranial haemorrhage and electrolyte disturbances. From the 128 patients eligible, 88 were included in the study. INTERVENTION Random assignment of patients to either a saline colloid (6% hydroxyethyl starch 130/0.4 in 0.9% NaCl) or a balanced-electrolyte colloid (6% hydroxyethyl starch 130/0.4 in an isotonic solution) for CPB priming and intra- and postoperative fluid therapy during the first postoperative 48 h. MAIN OUTCOME MEASURE The primary outcome measure was calculated blood loss until the third postoperative day (POD3). RESULTS A total of 44 patients were included in each study arm. Calculated blood loss at POD3 was not significantly different between the groups (saline colloid 19.9 [IQR 13.8 to 26.1] ml kg−1 versus balanced colloid 15.9 [IQR 9.0 to 25.3 ml kg−1], P = 0.409). Secondary outcomes related to bleeding, exposure to blood products and coagulation were not different between groups. There was also no difference in length of mechanical ventilation, intensive care and hospital length of stay between groups. CONCLUSION The use of a balanced colloid for peri-operative fluid therapy compared with a saline one is not associated with decreased blood loss or exposure to blood products. TRIAL REGISTRATION EudraCT identifier: 2012-006034-17 and ClinicalTrial.gov identifier: NCT02584868.


  • Open Access

    Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis

    by Ariane Willems, Peter P Roeleveld, Sonia Labarinas, John W Cyrus, Jennifer A Muszynski, Marianne E Nellis, Oliver Karam

    The purpose was to compare time-based vs anti-Xa-based anticoagulation strategies in patients on ECMO. We conducted a systematic review and meta-analysis using multiple electronic databases and included studies from inception to July 19, 2019. The proportion of bleeding, thrombosis, and mortality were evaluated. Twenty-six studies (2,086 patients) were included. Bleeding occurred in 34.2% (95%CI 25.1;43.9) of the patients with anti-Xa-based versus 41.6% (95%CI 24.9;59.4) of the patients with time-based anticoagulation strategies. Thrombosis occurred in 32.6% (95%CI 19.1;47.7) of the patients with anti-Xa-based versus 38.4% (95%CI 22.2;56.1) of the patients with time-based anticoagulation strategies. And mortality rate was 35.4% (95%CI 28.9;42.1) of the patients with anti-Xa-based versus 42.9% (95%CI 36.9;48.9) of the patients with time-based anticoagulation strategies. Among the seven studies providing results from both anticoagulation strategies, significantly fewer bleeding events occurred in the anti-Xa-based anticoagulation strategy (adjusted OR 0.49 (95%CI 0.32;0.74), p < 0.001) and a significantly lower mortality rate (adjusted OR 0.61 (95%CI 0.40;0.95), p = 0.03). There was no significant difference in thrombotic events (adjusted OR 0.91 (95%CI 0.56;1.49), p = 0.71). In these seven observational studies, only a small fraction of the patients were adults, and data were insufficient to analyze the effect of the type of ECMO. In this meta-analysis of observational studies of patients on ECMO, an anti-Xa-based anticoagulation strategy, when compared to a time-based strategy, was associated with fewer bleeding events and mortality rate, without an increase in thrombotic events.